Pharmaceuticals , Inc. (Nasdaq:ALNY), a leading RNAi therapeutics
company, announced today its pipeline growth strategy for development
and commercialization of RNAi therapeutics across three Strategic
Therapeutic Areas (STArs): Genetic Medicines, Cardio-metabolic Disease,
and Hepatic Infectious Disease.
for Alnylam Introduces Pipeline Growth Strategy for RNAi Therapeutics in Three Strategic Therapeutic Areas, or “STArs” investment picks